[go: up one dir, main page]

UA96736C2 - Pi3k inhibitors for the treatment of endometriosis - Google Patents

Pi3k inhibitors for the treatment of endometriosis

Info

Publication number
UA96736C2
UA96736C2 UAA200801628A UAA200801628A UA96736C2 UA 96736 C2 UA96736 C2 UA 96736C2 UA A200801628 A UAA200801628 A UA A200801628A UA A200801628 A UAA200801628 A UA A200801628A UA 96736 C2 UA96736 C2 UA 96736C2
Authority
UA
Ukraine
Prior art keywords
endometriosis
treatment
pi3k inhibitors
pi3k inhibitor
relates
Prior art date
Application number
UAA200801628A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Стивен С. Палмер
Селварадж Натараджа
Original Assignee
Мерк Сероно Са
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Мерк Сероно Са filed Critical Мерк Сероно Са
Publication of UA96736C2 publication Critical patent/UA96736C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

This invention relates to a method of treating and/or preventing endometriosis comprising administering a PI3K inhibitor. The PI3K inhibitor can also be administered combined with a hormonal suppressor. The invention further relates to the treatment of endometriosis-related infertility.
UAA200801628A 2005-09-07 2006-08-28 Pi3k inhibitors for the treatment of endometriosis UA96736C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71464405P 2005-09-07 2005-09-07

Publications (1)

Publication Number Publication Date
UA96736C2 true UA96736C2 (en) 2011-12-12

Family

ID=40079569

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200801628A UA96736C2 (en) 2005-09-07 2006-08-28 Pi3k inhibitors for the treatment of endometriosis

Country Status (4)

Country Link
JP (1) JP2009507072A (en)
CN (1) CN101300047A (en)
UA (1) UA96736C2 (en)
ZA (1) ZA200802080B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101965408B (en) * 2008-02-04 2013-08-28 塞尔卓姆有限责任公司 Selectivity profiling of PI3k interacting molecules against multiple targets
JO3398B1 (en) * 2011-12-22 2019-10-20 Novartis Ag 2,3-Dihydro-benzo[1,4]oxazine derivatives and related compounds as phosphoinositide-3 kinase (PI3K) inhibitors for the treatment of e.g. rheumatoid arthritis
TW201422625A (en) * 2012-11-26 2014-06-16 Novartis Ag Solid form of dihydro-pyrido-oxazine derivative
CN108570043A (en) * 2018-06-20 2018-09-25 王延娇 A kind of compound and its alternatively application of the property PI3K inhibitor in treating tumour

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011807B1 (en) * 2002-07-10 2009-06-30 Лаборатуар Сероно Са Azolidinone-vinyl fused-benzene derivatives
AU2003255529B2 (en) * 2002-07-10 2008-11-20 Laboratoires Serono Sa Use of compounds for increasing spermatozoa motility
WO2004048525A2 (en) * 2002-11-21 2004-06-10 Genentech, Inc. Therapy of non-malignant diseases or disorders with anti-erbb2 antibodies
ES2328146T3 (en) * 2003-07-28 2009-11-10 Merck Serono Sa 2-IMINO-4- (UNCLE) OXO-5-POLYCYCLEVINYLOLINES FOR USE AS INHIBITORS OF P13 KINASES.

Also Published As

Publication number Publication date
JP2009507072A (en) 2009-02-19
CN101300047A (en) 2008-11-05
ZA200802080B (en) 2009-09-30

Similar Documents

Publication Publication Date Title
EA200800755A1 (en) IKK INHIBITORS INTRODUCED FOR THE TREATMENT OF ENDOMETRIOSIS
MY150697A (en) Methods of treating cancer using pyridopyrimdinone inhibitors of p13k alpha
MX2008011633A (en) Aminoquinolones as gsk-3 inhibitors.
TN2010000209A1 (en) Treatment of uterine cancer and ovarian cancer with a parp inhibitor alone or in combination with anti-tumor agents
MX366119B (en) Methods for treating conditions associated with masp-2 dependent complement activation.
MY150797A (en) Combination therapies comprising quinaxoline inhibitors of pi3k-alpha for use in the treatment of cancer
MX350455B (en) Dpp-iv inhibitors for use in the treatment of nafld.
JO2886B1 (en) Compounds useful for inhibiting chk1
MX2010002667A (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors.
TN2012000205A1 (en) Method and compositions for treating solid tumors and other malignancies
WO2007121279A3 (en) Cancer treatment method
WO2007030360A3 (en) P13k inhibitors for the treatment of endometriosis
UA96736C2 (en) Pi3k inhibitors for the treatment of endometriosis
DK2041181T3 (en) Specific protease inhibitors and their use in cancer therapy
WO2007149543A3 (en) Scar treatment using protein phosphatase inhibitors
WO2006081371A3 (en) Combination therapy with triterpenoid compounds and proteasome inhibitors
WO2008063853A3 (en) Cancer treatment method
WO2007136615A3 (en) Combination cancer therapy
ZA200710497B (en) Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
SG165343A1 (en) Jnk inhibitors for the treatment of endometriosis
NZ617989A (en) Use of pnp inhibitors such as forodesine in combination with alkylating agents for treating hematologic cancers
TW200642688A (en) New use of PDE7 inhibitors
NO20080782L (en) JNK inhibitors for the treatment of endometriosis
TW200603792A (en) Monotherapy for the treatment of psoriasis with cyclooxygenase-2 selective inhibitors
UA89242C2 (en) Method for the treatment of endometreosis by use of jnk inhibitor which is a benzothiazole derivative